ANDE

ANDE
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.678B ▼ | $172.554M ▲ | $20.138M ▲ | 0.752% ▲ | $0.592 ▲ | $71.066M ▼ |
| Q2-2025 | $3.136B ▲ | $134.589M ▼ | $7.857M ▲ | 0.251% ▲ | $0.23 ▲ | $71.478M ▲ |
| Q1-2025 | $2.659B ▼ | $145.754M ▲ | $284K ▼ | 0.011% ▼ | $0.01 ▼ | $52.723M ▼ |
| Q4-2024 | $3.123B ▲ | $144.754M ▲ | $45.09M ▲ | 1.444% ▲ | $1.32 ▲ | $116.812M ▲ |
| Q3-2024 | $2.621B | $120.494M | $27.365M | 1.044% | $0.8 | $104.155M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $86.788M ▼ | $3.297B ▼ | $2.074B ▲ | $1.181B ▼ |
| Q2-2025 | $350.97M ▲ | $3.446B ▼ | $1.836B ▼ | $1.364B ▲ |
| Q1-2025 | $219.219M ▼ | $3.798B ▼ | $2.203B ▼ | $1.356B ▼ |
| Q4-2024 | $561.771M ▲ | $4.121B ▲ | $2.521B ▲ | $1.366B ▲ |
| Q3-2024 | $454.065M | $3.388B | $1.865B | $1.329B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $20.138M ▲ | $233.882M ▼ | $-476.593M ▼ | $-25.969M ▲ | $-269.34M ▼ | $167.048M ▼ |
| Q2-2025 | $16.807M ▲ | $299.321M ▲ | $-31.876M ▲ | $-137.453M ▼ | $131.751M ▲ | $250.493M ▲ |
| Q1-2025 | $5.331M ▼ | $-350.02M ▼ | $-43.831M ▲ | $50.445M ▲ | $-342.552M ▼ | $-396.568M ▼ |
| Q4-2024 | $54.104M ▲ | $268.811M ▲ | $-72.482M ▼ | $-87.764M ▼ | $107.706M ▲ | $212.854M ▲ |
| Q3-2024 | $51.461M | $-2.112M | $-32.454M | $-42.669M | $-76.321M | $-39.953M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Agribusiness Segment | $0 ▲ | $1.99Bn ▲ | $2.41Bn ▲ | $1.99Bn ▼ |
Renewables | $710.00M ▲ | $670.00M ▼ | $720.00M ▲ | $690.00M ▼ |
Plant Nutrient | $190.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Trade | $2.22Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
The Andersons today looks like a more resilient, better balanced version of itself compared with five years ago. Earnings quality and margins have improved even as revenue has come off earlier highs, the balance sheet has strengthened with more cash and less relative debt, and cash flow has turned sustainably positive. Competitively, its integrated network, diversified segments, and specialty products create meaningful advantages, though it cannot escape the inherent volatility and policy risk of global agriculture and biofuels. Its ongoing push into higher‑margin nutrients, digital tools, sustainability, and low‑carbon renewables offers tangible growth and differentiation opportunities, but also requires continued investment and careful execution in a cyclical, weather‑ and regulation‑sensitive industry.
NEWS
November 17, 2025 · 4:05 PM UTC
The Andersons to Present at Stephens Annual Investment Conference
Read more
November 4, 2025 · 4:05 PM UTC
The Andersons, Inc. Reports Third Quarter Results
Read more
October 14, 2025 · 4:05 PM UTC
The Andersons, Inc. to Release Third Quarter Results on November 4
Read more
September 3, 2025 · 4:05 PM UTC
The Andersons, Inc. to Host 2025 Investor Day
Read more
About The Andersons, Inc.
https://andersonsinc.comThe Andersons, Inc., an agriculture company, operates in trade, renewables, and plant nutrient sectors in the United States and internationally. The company's Trade segment operates grain elevators; stores commodities; and provides grain marketing, risk management, and origination services to its customers and affiliated ethanol facilities.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.678B ▼ | $172.554M ▲ | $20.138M ▲ | 0.752% ▲ | $0.592 ▲ | $71.066M ▼ |
| Q2-2025 | $3.136B ▲ | $134.589M ▼ | $7.857M ▲ | 0.251% ▲ | $0.23 ▲ | $71.478M ▲ |
| Q1-2025 | $2.659B ▼ | $145.754M ▲ | $284K ▼ | 0.011% ▼ | $0.01 ▼ | $52.723M ▼ |
| Q4-2024 | $3.123B ▲ | $144.754M ▲ | $45.09M ▲ | 1.444% ▲ | $1.32 ▲ | $116.812M ▲ |
| Q3-2024 | $2.621B | $120.494M | $27.365M | 1.044% | $0.8 | $104.155M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $86.788M ▼ | $3.297B ▼ | $2.074B ▲ | $1.181B ▼ |
| Q2-2025 | $350.97M ▲ | $3.446B ▼ | $1.836B ▼ | $1.364B ▲ |
| Q1-2025 | $219.219M ▼ | $3.798B ▼ | $2.203B ▼ | $1.356B ▼ |
| Q4-2024 | $561.771M ▲ | $4.121B ▲ | $2.521B ▲ | $1.366B ▲ |
| Q3-2024 | $454.065M | $3.388B | $1.865B | $1.329B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $20.138M ▲ | $233.882M ▼ | $-476.593M ▼ | $-25.969M ▲ | $-269.34M ▼ | $167.048M ▼ |
| Q2-2025 | $16.807M ▲ | $299.321M ▲ | $-31.876M ▲ | $-137.453M ▼ | $131.751M ▲ | $250.493M ▲ |
| Q1-2025 | $5.331M ▼ | $-350.02M ▼ | $-43.831M ▲ | $50.445M ▲ | $-342.552M ▼ | $-396.568M ▼ |
| Q4-2024 | $54.104M ▲ | $268.811M ▲ | $-72.482M ▼ | $-87.764M ▼ | $107.706M ▲ | $212.854M ▲ |
| Q3-2024 | $51.461M | $-2.112M | $-32.454M | $-42.669M | $-76.321M | $-39.953M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Agribusiness Segment | $0 ▲ | $1.99Bn ▲ | $2.41Bn ▲ | $1.99Bn ▼ |
Renewables | $710.00M ▲ | $670.00M ▼ | $720.00M ▲ | $690.00M ▼ |
Plant Nutrient | $190.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Trade | $2.22Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
The Andersons today looks like a more resilient, better balanced version of itself compared with five years ago. Earnings quality and margins have improved even as revenue has come off earlier highs, the balance sheet has strengthened with more cash and less relative debt, and cash flow has turned sustainably positive. Competitively, its integrated network, diversified segments, and specialty products create meaningful advantages, though it cannot escape the inherent volatility and policy risk of global agriculture and biofuels. Its ongoing push into higher‑margin nutrients, digital tools, sustainability, and low‑carbon renewables offers tangible growth and differentiation opportunities, but also requires continued investment and careful execution in a cyclical, weather‑ and regulation‑sensitive industry.
NEWS
November 17, 2025 · 4:05 PM UTC
The Andersons to Present at Stephens Annual Investment Conference
Read more
November 4, 2025 · 4:05 PM UTC
The Andersons, Inc. Reports Third Quarter Results
Read more
October 14, 2025 · 4:05 PM UTC
The Andersons, Inc. to Release Third Quarter Results on November 4
Read more
September 3, 2025 · 4:05 PM UTC
The Andersons, Inc. to Host 2025 Investor Day
Read more

CEO
William E. Krueger
Compensation Summary
(Year 2024)

CEO
William E. Krueger
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-02-19 | Forward | 3:2 |
| 2006-06-29 | Forward | 2:1 |
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK, INC.
5.292M Shares
$272.525M

BLACKROCK INC.
5.271M Shares
$271.442M

VANGUARD GROUP INC
4.08M Shares
$210.095M

DIMENSIONAL FUND ADVISORS LP
2.332M Shares
$120.096M

BLACKROCK FUND ADVISORS
2.128M Shares
$109.603M

STATE STREET CORP
1.417M Shares
$72.963M

GEODE CAPITAL MANAGEMENT, LLC
819.553K Shares
$42.207M

RUSSELL FRANK CO/
785.2K Shares
$40.438M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
713.42K Shares
$36.741M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
631.151K Shares
$32.504M

D. E. SHAW & CO., INC.
584.967K Shares
$30.126M

WALNUT LEVEL CAPITAL LLC
574.744K Shares
$29.599M

NORTHERN TRUST CORP
566.453K Shares
$29.172M

EMERALD ACQUISITION LTD.
547.472K Shares
$28.195M

INVESCO LTD.
509.82K Shares
$26.256M

AMERIPRISE FINANCIAL INC
506.222K Shares
$26.07M

JACOBS LEVY EQUITY MANAGEMENT, INC
438.219K Shares
$22.568M

QUBE RESEARCH & TECHNOLOGIES LTD
373.196K Shares
$19.22M

GOLDMAN SACHS GROUP INC
372.42K Shares
$19.18M

MORGAN STANLEY
353.811K Shares
$18.221M
Summary
Only Showing The Top 20




